The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C

Clinical Transplantation

Volumn 28, Issue 8, 2014, Pages 862-868

  Morbitzer, Kathryn A ^a,b   Taber, David J ^c   Pilch, Nicole A ^b   Meadows, Holly B ^b   Fleming, James N ^b   Bratton, Charles F ^c   Mcgillicuddy, John W ^c   Baliga, Prabhakar K ^c   Chavin, Kenneth D ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood glucose; Fibrosis; Graft loss; New onset diabetes after transplant; Recurrence

Indexed keywords

GLUCOSE BLOOD LEVEL;

ADULT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENICITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLYCEMIC INDEX; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84905586411     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12391     Document Type: Article

References (23)

1. Gane EJ. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences. Am J Transplant 2012: 12: 531.
2. Rosen H. Chronic hepatitis C infection. N Engl J Med 2011: 364: 2429.
3. Bloom RD, Lake JR. Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients. Am J Transplant 2006: 6: 2232.
4. D'Souza R, Sabin C, Foster G. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005: 100: 1509.
5. Hanouneh I, Feldstein A, McCullough A et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008: 14: 1287.
6. Veldt BJ, Poterucha JJ, Watt KD et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2009: 9: 1406.
7. Patel A, Harrison S. Hepatitis C virus infection and nonalcoholic steatohepatitis. Gastroenterol Hepatol 2012: 8: 305.
8. Khalil M, Lim J, Bass N, Ascher N, Roberts J, Terrault N. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004: 10: 349.
9. Foxton MR, Quaglia A, Muiesan P et al. The impact of diabetes mellitus on fibrosis progression in patients transplant for hepatitis C. Am J Transplant 2006: 6: 1922.
10. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000: 31: 545.
11. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013: 36: S11.
12. Pham P, Pham P, Lipshutz G, Wilkinson A. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 2007: 36: 873.
13. Ponziani FR, Gasbarrini A, Pompili M, Burra P, Fagiuoli S. Management of hepatitis C virus infection recurrence after liver transplantation: an overview. Transplant Proc 2011: 43: 291.
14. Gallegos-Orozco J, Yosephy A, Noble B et al. Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course. Liver Transpl 2009: 15: 1872.
15. Levitsky J, Doucette K. Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009: 9(s4): s116.
16. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005: 19: 291.
17. Pavlakis M. New-onset diabetes after transplantation. Curr DiabRep 2005: 5: 300.
18. Baid S, Cosimi A, Farrell M et al. Post transplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001: 72: 1066.
19. AlDosary A, Ramji A, Elliott T et al. Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transpl 2002: 8: 356.
20. Pham PT, Pham PM, Pham SV, Pham PA, Pham PC. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 2011: 4: 175.
21. Bodziak K, Hricik D. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009: 22: 519.
22. Delgado-Borrego A, Casson D, Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004: 77: 703.
23. Saliba F, Lakehal M, Pageaux G et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl 2007: 13: 136.